Retinoblastoma: A Rare Childhood Eye Tumor
Author Information
Author(s): Aerts Isabelle, Lumbroso-Le Rouic Livia, Gauthier-Villars Marion, Brisse Hervé, Doz François, Desjardins Laurence
Primary Institution: Institut Curie, Paris, France
Conclusion
The prognosis for retinoblastoma is excellent in patients with unilateral or bilateral forms, with a cure rate of 95% in industrialized countries.
Supporting Evidence
- Retinoblastoma is the most common intraocular malignancy of infancy and childhood.
- 60% of retinoblastomas are unilateral and most of these forms are not hereditary.
- Hereditary retinoblastoma has a greater than 90% risk of developing the disease.
- Diagnosis is made by fundoscopy, with imaging techniques aiding in assessment.
- Long-term follow-up is necessary due to the risk of second primary tumors.
Takeaway
Retinoblastoma is a rare eye cancer in children that can be treated effectively, especially if caught early. Most kids can survive and keep their vision.
Methodology
Diagnosis is made through fundoscopy, and imaging techniques like ultrasound, MRI, and CT scans are used for assessment.
Limitations
The study does not address the high mortality rate in developing countries due to delayed diagnosis.
Participant Demographics
Most affected children are diagnosed before the age of five years, with a median age of diagnosis at two years for unilateral cases and one year for bilateral cases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website